Company Filing History:
1 out of 894 
1 out of 344 
Years Active: 2003-2014
Title: Shimon Ben Shabat: Innovator in Cannabinoid Research
Introduction
Shimon Ben Shabat is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of cannabinoid research, holding 2 patents that focus on novel compounds with therapeutic potential. His work has implications for treating various cancers and inflammatory diseases.
Latest Patents
One of his latest patents is titled "Substituted cyclohexylidene-ethylidene-octahydro-indene compounds." This invention describes novel compounds that exhibit profound anti-proliferative effects, making them promising candidates for cancer treatment. The compounds are noted for their ability to combat hyperproliferative diseases and disorders.
Another significant patent is "Synthetic endogenous cannabinoids analogues and uses thereof." This invention relates to a non-hydrolysable analogue of endogenous cannabinoids, which are more stable and potent therapeutic agents. The cannabinoid analogues developed by Ben Shabat have therapeutic value and can be used in various pharmaceutical compositions for treating conditions such as glaucoma, migraine, and multiple sclerosis.
Career Highlights
Shimon Ben Shabat has worked with esteemed institutions, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Ben-Gurion University of the Negev Research and Development Authority. His career reflects a commitment to advancing cannabinoid research and its applications in medicine.
Collaborations
Throughout his career, Ben Shabat has collaborated with prominent figures in the field, including Raphael Mechoulam and Esther Fride. These collaborations have further enriched his research and contributed to the development of innovative therapeutic solutions.
Conclusion
Shimon Ben Shabat's work in cannabinoid research exemplifies the potential of innovative compounds in medical applications. His patents reflect a dedication to improving treatment options for various diseases, showcasing the importance of research in advancing healthcare solutions.